Viemed Healthcare

Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Viemed Healthcare (VMD) surpasses Q3 revenue expectations, eyes strong 2025

Viemed Healthcare (VMD) delivered strong Q3 results, setting revenue records and showcasing operational improvements.
The company's focus on patient outcomes, regulatory advocacy, and strategic investments positions it for future growth.
Challenges include maintaining operational excellence, managing expenses, and navigating potential therapy impacts.
Viemed's opportunities lie in continued growth, regulatory developments, and strategic expansion for a positive outlook.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of -33.33% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Viemed Healthcare, Inc. (VMD) Lags Q1 Earnings Estimates

LAFAYETTE, La., May 03, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, announced today that it has reported its financial results for the three months ended March 31, 2022.

Viemed Healthcare Announces First Quarter 2022 Financial Results

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q4 2021 Results - Earnings Call Transcript

LAFAYETTE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, today reported that its Board of Directors has authorized and approved a share repurchase program on Nasdaq.

Viemed Healthcare Announces Share Repurchase Program

LAFAYETTE, La., March 07, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, today reported its financial results for the three months and year ended December 31, 2021.

Viemed Healthcare Announces 2021 Financial Results

By solving problems and genuinely helping people, Viemed will continue to grow. Core business grows by 12% sales-wise in Q3.

Viemed Healthcare: New Bullish Trend Has Just Begun

LAFAYETTE, La., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD and TSX: VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, announced today that the Company's Chief Medical Officer, Dr. William Frazier, ABIM Board Certified in Internal, Pulmonary, Critical Care, and Sleep Disorders Medicine and leader of two peer reviewed clinical studies (the “recent studies”) concerning the benefits of Non-Invasive Ventilation at Home (NIVH) therapy in COPD-CRF patients, will be sharing his professional insights and perspective during a free public Webinar on December 9 at 12:00 p.m. EST.

Viemed Healthcare Announces Principal Physician Researcher to Present Latest Clinical Findings

The consensus price target hints at an 111.9% upside potential for Viemed Healthcare, Inc. (VMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Can Viemed Healthcare, Inc. (VMD) Climb 112% to Reach the Level Wall Street Analysts Expect?

LAFAYETTE, La., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, announced today that Casey Hoyt, Chief Executive Officer, and Todd Zehnder, Chief Operating Officer will meet virtually with investors and present at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021 at 9:20 A.M. ET.

Viemed Healthcare to Present at the Stifel 2021 Virtual Healthcare Conference

Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of -20.00% and 5.34%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Viemed Healthcare, Inc. (VMD) Lags Q3 Earnings Estimates

LAFAYETTE, La., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, today reported its financial results for the three and nine months ended September 30, 2021.

Viemed Healthcare Announces Third Quarter 2021 Financial Results

Viemed Healthcare, Inc. (VMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Viemed Healthcare, Inc. (VMD) to Report a Decline in Earnings: What to Look Out for

LAFAYETTE, La., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, announced another published non-invasive ventilation study led by Dr. William Frazier, Viemed's Chief Medical Officer. The study, entitled “Noninvasive Ventilation at Home Reduces Mortality in COPD With CRF”, was published on September 15, 2021, in the on-line edition of The American Journal of Managed Care, a respected, peer reviewed journal. (https://www.ajmc.com/view/noninvasive-ventilation-at-home-reduces-mortality-in-copd-with-crf)

Viemed Healthcare Announces Second Published Non-Invasive Ventilation Study

Viemed Healthcare's (VMD) CEO Casey Hoyt on Q2 2021 Results - Earnings Call Transcript

Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of 100.00% and -0.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Viemed Healthcare, Inc. (VMD) Surpasses Q2 Earnings Estimates

LAFAYETTE, La., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, announced today that it has reported its financial results for the three and six months ended June 30, 2021.

Viemed Healthcare Announces Second Quarter 2021 Financial Results

Earnings Preview: Viemed Healthcare, Inc. (VMD) Q2 Earnings Expected to Decline

LAFAYETTE, La., June 10, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO and NASDAQ:VMD), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, today announced the voting results from its annual and special meeting of shareholders held on June 10, 2021 (the “Meeting”) in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 25,380,544, representing 64.13% of the total issued and outstanding shares in the capital of the Company.

Viemed Healthcare Announces Voting Results From Its Annual & Special Meeting of Shareholders

Viemed Healthcare Inc. ( VMD , Financial) is an at-home medical service provider using medical devices to increase quality of life in the homes of patients with respiratory diseases.

Viemed: Steep Growth at a Reasonable Price

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q1 2021 Results - Earnings Call Transcript

Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of 33.33% and -2.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Viemed Healthcare, Inc. (VMD) Q1 Earnings Top Estimates

LAFAYETTE, La., May 03, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has reported its financial results for the three months ended March 31, 2021.

Viemed Healthcare Announces First Quarter 2021 Financial Results

BioDelivery Sciences

Co-Diagnostics

Kamada

Surface Oncology Inc

As of April 21, the GuruFocus All-in-One Screener, a Premium feature, found that the following guru-owned utilities have low price-earnings ratios. While some of them are great value investments, others may need to be researched more carefully, according to the discounted cash flow calculator.

5 Health Care Stocks Trading with Low Price-Earnings Ratios

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q4 2020 Results - Earnings Call Transcript

LAFAYETTE, La., March 03, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has reported its financial results for the three months and year ended December 31, 2020.

News for Viemed Healthcare Stock (VMD)